Clinical and genomic characterization of Low PSA Secretors: a unique subset of metastatic castration resistant prostate cancer.
Rahul AggarwalGustavo Rubio RomeroVerena FriedlAlana S WeinsteinAdam FoyeJiaoti HuangFelix FengJoshua M StuartEric J SmallPublished in: Prostate cancer and prostatic diseases (2020)
Low PSA secretion in relation to metastatic tumor burden may be a readily available clinical selection tool for de-differentiated mCRPC with molecular features consistent with t-SCNC. Prospective validation is warranted.